+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

3SBio Inc (1530) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 48 Pages
  • August 2024
  • GlobalData
  • 3SBio Inc
  • ID: 4315251
3SBio Inc (1530) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

3SBio Inc (3SBio) is a biotechnology company that discovers, develops, manufactures and markets biopharmaceutical products. The company develops recombinant or genetically engineered, protein-based products and other pharmaceutical product candidates to meet significant unmet medical needs in the areas of cancer and its supportive care, hematology, nephrology and dermatology among other disease conditions. The company distributes its products to hospitals, clinics and dialysis centers in China. The company sells its products in various countries including Thailand, Brazil, the Philippines and Pakistan among others. 3SBio is headquartered in Shenyang, Liaoning, China.

3SBio Inc Key Recent Developments

  • Aug 24, 2023: 3SBio : Interim Results Announcement for the Six Months Ended 30 June 2023
  • Jul 28, 2023: 3SBio: Appointment of Chief Financial Officer
  • Jul 28, 2023: 3SBio Announces Appointment of Chief Financial Officer
  • Mar 21, 2023: 3SBio : Annual Results Announcement for the Year Ended 31 December 2022

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • 3SBio Inc - Key Facts
  • 3SBio Inc - Key Employees
  • 3SBio Inc - Key Employee Biographies
  • 3SBio Inc - Major Products and Services
  • 3SBio Inc - History
  • 3SBio Inc - Company Statement
  • 3SBio Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • 3SBio Inc - Business Description
  • Other Break-up: Contract Development and Manufacturing Operation Business
  • Performance
  • Other Break-up: Sale of Biopharmaceuticals
  • Performance
  • Geographical Segment: Mainland China
  • Performance
  • Geographical Segment: Others
  • Performance
  • R&D Overview
  • 3SBio Inc - Corporate Strategy
  • 3SBio Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • 3SBio Inc - Strengths
  • 3SBio Inc - Weaknesses
  • 3SBio Inc - Opportunities
  • 3SBio Inc - Threats
  • 3SBio Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • 3SBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • 3SBio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • 3SBio Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Aug 24, 2023: 3SBio : Interim Results Announcement for the Six Months Ended 30 June 2023
  • Jul 28, 2023: 3SBio: Appointment of Chief Financial Officer
  • Jul 28, 2023: 3SBio Announces Appointment of Chief Financial Officer
  • Mar 21, 2023: 3SBio : Annual Results Announcement for the Year Ended 31 December 2022
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • 3SBio Inc, Key Facts
  • 3SBio Inc, Key Employees
  • 3SBio Inc, Key Employee Biographies
  • 3SBio Inc, Major Products and Services
  • 3SBio Inc, History
  • 3SBio Inc, Other Locations
  • 3SBio Inc, Subsidiaries
  • 3SBio Inc, Key Competitors
  • 3SBio Inc, Ratios based on current share price
  • 3SBio Inc, Annual Ratios
  • 3SBio Inc, Interim Ratios
  • 3SBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • 3SBio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • 3SBio Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • 3SBio Inc, Performance Chart (2019 - 2023)
  • 3SBio Inc, Ratio Charts
  • 3SBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • 3SBio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Samples

Loading
LOADING...

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Nanjing Hencer Pharmaceutical Co Ltd
  • CapitalBio Corp
  • Kexing Biopharm Co Ltd
  • Hubei Guangji Pharmaceutical Co Ltd
  • Harbin Pharmaceutical Group Holding Co Ltd
  • China Intertrade Ltd
  • Zhejiang Raybow Pharmaceutical Co Ltd